Andrew Samuelson, Ph.D.

Andrew Samuelson, Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 633
Rochester, NY 14642

Office: (585) 273-2409
Administrative: (585) 273-1440


The biographical information for Andrew Samuelson, Ph.D. is not currently available.

Recent Journal Articles

Showing the 5 most recent journal articles. 6 available »

Ruvkun, G.; Samuelson, A.V.; Carr, C.E.; Curran, S.P.; and Shore, D.E. "Signaling Pathways that Regulate C. elegans Life Span". Research and Perspectives in Endocrine Interactions. 2009; : 69-84.
Chakraborty A.A.; Tworkowski K.A.; Samuelson A.V.; Seger Y.R.; Narita M.; Hannon G.J.; Lowe S.W.; and Tansey W.P. "Adenovirus E1A targets p400 to induce the cellular oncoprotein Myc". Proc. Natl. Acad. Sci. 2008; 105: 6103-8.
Samuelson A.V.; Carr C.E.; and Ruvkun G. "Gene activities that mediate increased lifespan of C. elegans insulin-like signaling mutants". Genes and Development. 2007; 21: 2976-94.
Samuelson A.V.; Narita M.; Chan H.M.; Jin J.; de Stanchina E.; McCurrach M.E.; Narita M.; Fuchs M.; Livingston D.M.; Lowe S.W. "p400 is required for E1A to promote apoptosis". J. Biol. Chem. 2005; 280: 21915-23.
de Stanchina E.; McCurrach M.E.; Zindy F.; Shieh S.Y.; Ferbeyre G.; Samuelson A.V.; Prives C.; Roussel M.F.; Sherr C.J.; and Lowe S.W. (. "E1A signaling to p53 involves the p19(ARF) tumor suppressor". Genes and Development. 1998; 12: 2434-42.

Post-Doctoral Training & Residency

Research Fellow, Department of Genetics, Harvard Medical School and Department of Molecular Biology, Massachusetts General Hospital 2009